CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Capital in Excess of Par Value	Equity Consideration Payable	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023		29,386,000
Beginning balance at Dec. 31, 2023	$ 333,065	$ 584	$ 625,154	$ 0	$ (274,956)	$ (939)	$ (16,778)
Treasury stock (in shares) at Dec. 31, 2023							1,356,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of stock options (in shares)		107,000
Issuance of common stock upon the exercise of stock options	1,105	$ 2	1,103
Net issuance of restricted stock awards and restricted stock units (in shares)		329,000
Net issuance of restricted stock awards and restricted stock units	0	$ 4	(4)
Issuance of common stock for acquisition (in shares)		442,000
Issuance of common stock for acquisition (see Note 3)	19,170	$ 9	19,161
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)							109,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock	(4,838)						$ (4,838)
Proceeds from private placement of common stock, net of issuance costs (in shares)		5,175,000
Proceeds from private placement of common stock, net of issuance costs of $5.5 million	194,490	$ 104	194,386
Stock-based compensation	4,410		4,410
Foreign currency translation adjustments	(2,714)					(2,714)
Net loss	(18,288)				(18,288)
Ending balance (in shares) at Mar. 31, 2024		35,439,000
Ending balance at Mar. 31, 2024	$ 526,400	$ 703	844,210	0	(293,244)	(3,653)	$ (21,616)
Treasury stock (in shares) at Mar. 31, 2024							1,465,000
Beginning balance (in shares) at Dec. 31, 2024	38,717,366	40,188,000
Beginning balance at Dec. 31, 2024	$ 871,710	$ 798	1,085,473	108,182	(279,943)	(20,951)	$ (21,849)
Treasury stock (in shares) at Dec. 31, 2024	1,470,305						1,470,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon the exercise of stock options (in shares)	9,000	8,000
Issuance of common stock upon the exercise of stock options	$ 215		215
Net issuance of restricted stock awards and restricted stock units (in shares)		382,000
Net issuance of restricted stock awards and restricted stock units	0	$ 6	(6)
Issuance of common stock for acquisition (in shares)		1,489,000
Issuance of common stock for acquisition (see Note 3)	0	$ 29	108,153	(108,182)
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock (in shares)							102,000
Treasury stock acquired from employees upon vesting or forfeiture of restricted stock	(7,015)						$ (7,015)
Stock-based compensation	7,181		7,181
Foreign currency translation adjustments	4,254					4,254
Net loss	$ (24,350)				(24,350)
Ending balance (in shares) at Mar. 31, 2025	40,494,785	42,067,000
Ending balance at Mar. 31, 2025	$ 851,995	$ 833	$ 1,201,016	$ 0	$ (304,293)	$ (16,697)	$ (28,864)
Treasury stock (in shares) at Mar. 31, 2025	1,572,398						1,572,000